Telomere length and cardiovascular aging: The means to the ends?

Ageing Research Reviews

Volumn 10, Issue 2, 2011, Pages 297-303

  De Meyer, Tim ^a   Rietzschel, Ernst R ^a   De Buyzere, Marc L ^a   Van Criekinge, Wim ^a   Bekaert, Sofie ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

Cardiovascular aging; Immunosenescence; Inflammation; Oxidative stress; Telomerase; Telomere

Indexed keywords

BIOLOGICAL MARKER; TELOMERASE;

AGING; ATHEROSCLEROSIS; CARDIOVASCULAR AGING; DISEASE PREDISPOSITION; ENDOTHELIAL PROGENITOR CELL; HEMATOPOIESIS; HUMAN; INFLAMMATION; INHERITANCE; LIFESTYLE; OXIDATIVE STRESS; RADIATION EXPOSURE; REVIEW; SENESCENCE; TELOMERE;

AGING; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; HUMANS; INFLAMMATION MEDIATORS; LIFE STYLE; OXIDATIVE STRESS; RISK FACTORS; TELOMERASE; TELOMERE;

EID: 79952454027     PISSN: 15681637     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arr.2010.11.001     Document Type: Review

References (68)

1. Adams M.J., Hardenbergh P.H., Constine L.S., Lipshultz S.E. Radiation-associated cardiovascular disease. Crit. Rev. Oncol. Hematol. 2003, 45:55-75.
2. Aviv A., Chen W., Gardner J.P., Kimura M., Brimacombe M., Cao X., Srinivasan S.R., Berenson G.S. Leukocyte telomere dynamics: longitudinal findings among young adults in the Bogalusa heart study. Am. J. Epidemiol. 2009, 169:323-329.
3. Aviv A., Valdes A.M., Spector T.D. Human telomere biology: pitfalls of moving from the laboratory to epidemiology. Int. J. Epidemiol. 2006, 35:1424-1429.
4. Ayouaz A., Raynaud C., Heride C., Revaud D., Sabatier L. Telomeres: hallmarks of radiosensitivity. Biochimie 2008, 90:60-72.
5. Bekaert S., De Meyer T., Rietzschel E.R., De Buyzere M.L., De Bacquer D., Langlois M., Segers P., Cooman L., Van Damme P., Cassiman P., Van Criekinge W., Verdonck P., De Backer G.G., Gillebert T.C., Van Oostveldt P. Telomere length and cardiovascular risk factors in a middle-aged population free of overt cardiovascular disease. Aging Cell 2007, 6:639-647.
6. Bekaert S., De Meyer T., Van Oostveldt P. Telomere attrition as ageing biomarker. Anticancer Res. 2005, 25:3011-3021.
7. Benetos A., Gardner J.P., Zureik M., Labat C., Xiaobin L., Adamopoulos C., Temmar M., Bean K.E., Thomas F., Aviv A. Short telomeres are associated with increased carotid atherosclerosis in hypertensive subjects. Hypertension 2004, 43:182-185.
8. Blasco M.A. Telomeres and human disease: ageing, cancer and beyond. Nat. Rev. Genet. 2005, 6:611-622.
9. Brouilette S.W., Moore J.S., McMahon A.D., Thompson J.R., Ford I., Shepherd J., Packard C.J., Samani N.J. Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland primary prevention study: a nested case-control study. Lancet 2007, 369:107-114.
10. Brouilette S.W., Whittaker A., Stevens S.E., van der Harst P., Goodall A.H., Samani N.J. Telomere length is shorter in healthy offspring of subjects with coronary artery disease: support for the telomere hypothesis. Heart 2008, 94:422-425.
11. Butler M.G., Tilburt J., DeVries A., Muralidhar B., Aue G., Hedges L., Atkinson J., Schwartz H. Comparison of chromosome telomere integrity in multiple tissues from subjects at different ages. Cancer Genet. Cytogenet. 1998, 105:138-144.
12. Cawthon R.M., Smith K.R., O'Brien E., Sivatchenko A., Kerber R.A. Association between telomere length in blood and mortality in people aged 60 years or older. Lancet 2003, 361:393-395.
13. Cherkas L.F., Hunkin J.L., Kato B.S., Richards J.B., Gardner J.P., Surdulescu G.L., Kimura M., Lu X., Spector T.D., Aviv A. The association between physical activity in leisure time and leukocyte telomere length. Arch. Intern. Med. 2008, 168:154-158.
14. Collerton J., Martin-Ruiz C., Kenny A., Barrass K., von Zglinicki T., Kirkwood T., Keavney B. Telomere length is associated with left ventricular function in the oldest old: the Newcastle 85+ study. Eur. Heart J. 2007, 28:172-176.
15. Das B., Saini D., Seshadri M. Telomere length in human adults and high level natural background radiation. PLoS ONE 2009, 4:e8440.
16. De la Fuente M., Miquel J. An update of the oxidation-inflammation theory of aging: the involvement of the immune system in oxi-inflamm-aging. Curr. Pharm. Des. 2009, 15:3003-3026.
17. De Meyer T., De Buyzere M.L., Langlois M., Rietzschel E.R., Cassiman P., De Bacquer D., Van Oostveldt P., De Backer G.G., Gillebert T.C., Van Criekinge W., Bekaert S. Lower red blood cell counts in middle-aged subjects with shorter peripheral blood leukocyte telomere length. Aging Cell 2008, 7:700-705.
18. De Meyer T., Rietzschel E.R., De Buyzere M.L., De Bacquer D., Van Criekinge W., De Backer G.G., Gillebert T.C., Van Oostveldt P., Bekaert S. Paternal age at birth is an important determinant of offspring telomere length. Hum. Mol. Genet. 2007, 16:3097-3102.
19. De Meyer T., Rietzschel E.R., De Buyzere M.L., Langlois M.R., De Bacquer D., Segers P., Van Damme P., De Backer G.G., Van Oostveldt P., Van Criekinge W., Gillebert T.C., Bekaert S. Systemic telomere length and preclinical atherosclerosis: the Asklepios study. Eur. Heart J. 2009, 30:3074-3081.
20. De Meyer T., Rietzschel E.R., De Buyzere M.L., Van Criekinge W., Bekaert S. Studying telomeres in a longitudinal population based study. Front. Biosci. 2008, 13:2960-2970.
21. Epel E.S., Lin J., Dhabhar F.S., Wolkowitz O.M., Puterman E., Karan L., Blackburn E.H. Dynamics of telomerase activity in response to acute psychological stress. Brain Behav. Immun. 2010, 24:531-539.
22. Epel E.S., Merkin S.S., Cawthon R., Blackburn E.H., Adler N.E., Pletcher M.J., Seeman T.E. The rate of leukocyte telomere shortening predicts mortality from cardiovascular disease in elderly men. Aging (Albany, NY) 2009, 1:81-88.
23. Farzaneh-Far R., Lin J., Epel E., Lapham K., Blackburn E., Whooley M.A. Telomere length trajectory and its determinants in persons with coronary artery disease: longitudinal findings from the heart and soul study. PLoS ONE 2010, 5:e8612.
24. Fitzpatrick A.L., Kronmal R.A., Gardner J.P., Psaty B.M., Jenny N.S., Tracy R.P., Walston J., Kimura M., Aviv A. Leukocyte telomere length and cardiovascular disease in the cardiovascular health study. Am. J. Epidemiol. 2007, 165:14-21.
25. Fuster J.J., Diez J., Andres V. Telomere dysfunction in hypertension. J. Hypertens. 2007, 25:2185-2192.
26. Goldman F.D., Aubert G., Klingelhutz A.J., Hills M., Cooper S.R., Hamilton W.S., Schlueter A.J., Lambie K., Eaves C.J., Lansdorp P.M. Characterization of primitive hematopoietic cells from patients with dyskeratosis congenita. Blood 2008, 111:4523-4531.
27. Groenveld H.F., Januzzi J.L., Damman K., van Wijngaarden J., Hillege H.L., van Veldhuisen D.J., van der Meer P. Anemia and mortality in heart failure patients a systematic review and meta-analysis. J. Am. Coll. Cardiol. 2008, 52:818-827.
28. Haendeler J., Hoffmann J., Diehl J.F., Vasa M., Spyridopoulos I., Zeiher A.M., Dimmeler S. Antioxidants inhibit nuclear export of telomerase reverse transcriptase and delay replicative senescence of endothelial cells. Circ. Res. 2004, 94:768-775.
29. Hagensen M.K., Shim J., Thim T., Falk E., Bentzon J.F. Circulating endothelial progenitor cells do not contribute to plaque endothelium in murine atherosclerosis. Circulation 2010, 121:898-905.
30. Hardy R., Lawlor D.A., Black S., Mishra G.D., Kuh D. Age at birth of first child and coronary heart disease risk factors at age 53 years in men and women: British birth cohort study. J. Epidemiol. Community Health 2009, 63:99-105.
31. Hjelmborg J.V., Nzietchueng R., Kimura M., Gardner J.P., Bladbjerg E.M., Christensen K., Aviv A., Benetos A. Leukocyte telomere length is inversely correlated with plasma Von Willebrand factor. Thromb. Res. 2010, 125:e339-342.
32. Imanishi T., Hano T., Nishio I. Angiotensin II accelerates endothelial progenitor cell senescence through induction of oxidative stress. J. Hypertens. 2005, 23:97-104.
33. Jeanclos E., Krolewski A., Skurnick J., Kimura M., Aviv H., Warram J.H., Aviv A. Shortened telomere length in white blood cells of patients with IDDM. Diabetes 1998, 47:482-486.
34. Jeanclos E., Schork N.J., Kyvik K.O., Kimura M., Skurnick J.H., Aviv A. Telomere length inversely correlates with pulse pressure and is highly familial. Hypertension 2000, 36:195-200.
35. Kappei D., Londono-Vallejo J.A. Telomere length inheritance and aging. Mech. Ageing Dev. 2008, 129:17-26.
36. Kimura M., Gazitt Y., Cao X., Zhao X., Lansdorp P.M., Aviv A. Synchrony of telomere length among hematopoietic cells. Exp. Hematol. 2010, 38:854-859.
37. Kurz D.J., Kloeckener-Gruissem B., Akhmedov A., Eberli F.R., Buhler I., Berger W., Bertel O., Luscher T.F. Degenerative aortic valve stenosis, but not coronary disease, is associated with shorter telomere length in the elderly. Arterioscler. Thromb. Vasc. Biol. 2006, 26:e114-117.
38. Liu J.P., Chen S.M., Cong Y.S., Nicholls C., Zhou S.F., Tao Z.Z., Li H. Regulation of telomerase activity by apparently opposing elements. Ageing Res. Rev. 2010, 9:245-256.
39. Mainous A.G., Codd V., Diaz V.A., Schoepf U.J., Everett C.J., Player M.S., Samani N.J. Leukocyte telomere length and coronary artery calcification. Atherosclerosis 2010, 210:262-267.
40. Minamino T., Miyauchi H., Yoshida T., Ishida Y., Yoshida H., Komuro I. Endothelial cell senescence in human atherosclerosis: role of telomere in endothelial dysfunction. Circulation 2002, 105:1541-1544.
41. Mirabello L., Huang W.Y., Wong J.Y., Chatterjee N., Reding D., Crawford E.D., De Vivo I., Hayes R.B., Savage S.A. The association between leukocyte telomere length and cigarette smoking, dietary and physical variables, and risk of prostate cancer. Aging Cell 2009, 8:405-413.
42. Nordfjall K., Svenson U., Norrback K.F., Adolfsson R., Lenner P., Roos G. The individual blood cell telomere attrition rate is telomere length dependent. PLoS Genet. 2009, 5:e1000375.
43. O'Donnell C.J., Demissie S., Kimura M., Levy D., Gardner J.P., White C., D'Agostino R.B., Wolf P.A., Polak J., Cupples L.A., Aviv A. Leukocyte telomere length and carotid artery intimal medial thickness: the Framingham heart study. Arterioscler. Thromb. Vasc. Biol. 2008, 28:1165-1171.
44. Ogami M., Ikura Y., Ohsawa M., Matsuo T., Kayo S., Yoshimi N., Hai E., Shirai N., Ehara S., Komatsu R., Naruko T., Ueda M. Telomere shortening in human coronary artery diseases. Arterioscler. Thromb. Vasc. Biol. 2004, 24:546-550.
45. Ornish D., Lin J., Daubenmier J., Weidner G., Epel E., Kemp C., Magbanua M.J., Marlin R., Yglecias L., Carroll P.R., Blackburn E.H. Increased telomerase activity and comprehensive lifestyle changes: a pilot study. Lancet Oncol. 2008, 9:1048-1057.
46. Passos J.F., Saretzki G., Ahmed S., Nelson G., Richter T., Peters H., Wappler I., Birket M.J., Harold G., Schaeuble K., Birch-Machin M.A., Kirkwood T.B., von Zglinicki T. Mitochondrial dysfunction accounts for the stochastic heterogeneity in telomere-dependent senescence. PLoS Biol. 2007, 5:e110.
47. Samani N.J., Boultby R., Butler R., Thompson J.R., Goodall A.H. Telomere shortening in atherosclerosis. Lancet 2001, 358:472-473.
48. Sarnak M.J., Tighiouart H., Manjunath G., MacLeod B., Griffith J., Salem D., Levey A.S. Anemia as a risk factor for cardiovascular disease in the atherosclerosis risk in communities (ARIC) study. J. Am. Coll. Cardiol. 2002, 40:27-33.
49. Satoh M., Minami Y., Takahashi Y., Tabuchi T., Itoh T., Nakamura M. Effect of intensive lipid-lowering therapy on telomere erosion in endothelial progenitor cells obtained from patients with coronary artery disease. Clin. Sci. (London) 2009, 116:827-835.
50. Shantsila E., Watson T., Lip G.Y. Endothelial progenitor cells in cardiovascular disorders. J. Am. Coll. Cardiol. 2007, 49:741-752.
51. Sidorov I., Kimura M., Yashin A., Aviv A. Leukocyte telomere dynamics and human hematopoietic stem cell kinetics during somatic growth. Exp. Hematol. 2009, 37:514-524.
52. Slagboom P.E., Droog S., Boomsma D.I. Genetic determination of telomere size in humans: a twin study of three age groups. Am. J. Hum. Genet. 1994, 55:876-882.
53. Spyridopoulos I., Erben Y., Brummendorf T.H., Haendeler J., Dietz K., Seeger F., Kissel C.K., Martin H., Hoffmann J., Assmus B., Zeiher A.M., Dimmeler S. Telomere gap between granulocytes and lymphocytes is a determinant for hematopoetic progenitor cell impairment in patients with previous myocardial infarction. Arterioscler. Thromb. Vasc. Biol. 2008, 28:968-974.
54. Spyridopoulos I., Haendeler J., Urbich C., Brummendorf T.H., Oh H., Schneider M.D., Zeiher A.M., Dimmeler S. Statins enhance migratory capacity by upregulation of the telomere repeat-binding factor TRF2 in endothelial progenitor cells. Circulation 2004, 110:3136-3142.
55. Spyridopoulos I., Hoffmann J., Aicher A., Brummendorf T.H., Doerr H.W., Zeiher A.M., Dimmeler S. Accelerated telomere shortening in leukocyte subpopulations of patients with coronary heart disease: role of cytomegalovirus seropositivity. Circulation 2009, 120:1364-1372.
56. Timmermans F., Plum J., Yoder M.C., Ingram D.A., Vandekerckhove B., Case J. Endothelial progenitor cells: identity defined?. J. Cell Mol. Med. 2009, 13:87-102.
57. Unryn B.M., Cook L.S., Riabowol K.T. Paternal age is positively linked to telomere length of children. Aging Cell 2005, 4:97-101.
58. Valdes A.M., Andrew T., Gardner J.P., Kimura M., Oelsner E., Cherkas L.F., Aviv A., Spector T.D. Obesity, cigarette smoking, and telomere length in women. Lancet 2005, 366:662-664.
59. van der Harst P., van der Steege G., de Boer R.A., Voors A.A., Hall A.S., Mulder M.J., van Gilst W.H., van Veldhuisen D.J. Telomere length of circulating leukocytes is decreased in patients with chronic heart failure. J. Am. Coll. Cardiol. 2007, 49:1459-1464.
60. van der Harst P., Wong L.S., de Boer R.A., Brouilette S.W., van der Steege G., Voors A.A., Hall A.S., Samani N.J., Wikstrand J., van Gilst W.H., van Veldhuisen D.J. Possible association between telomere length and renal dysfunction in patients with chronic heart failure. Am. J. Cardiol. 2008, 102:207-210.
61. von Zglinicki T., Pilger R., Sitte N. Accumulation of single-strand breaks is the major cause of telomere shortening in human fibroblasts. Free Radic. Biol. Med. 2000, 28:64-74.
62. Walne A.J., Dokal I. Advances in the understanding of dyskeratosis congenita. Br. J. Haematol. 2009, 145:164-172.
63. Willeit P., Willeit J., Brandstatter A., Ehrlenbach S., Mayr A., Gasperi A., Weger S., Oberhollenzer F., Reindl M., Kronenberg F., Kiechl S. Cellular aging reflected by leukocyte telomere length predicts advanced atherosclerosis and cardiovascular disease risk. Arterioscler. Thromb. Vasc. Biol. 2010, 30:1649-1656.
64. Wilson W.R., Herbert K.E., Mistry Y., Stevens S.E., Patel H.R., Hastings R.A., Thompson M.M., Williams B. Blood leucocyte telomere DNA content predicts vascular telomere DNA content in humans with and without vascular disease. Eur. Heart J. 2008, 29:2689-2694.
65. Wong L.S., Huzen J., van der Harst P., de Boer R.A., Codd V., Westenbrink B.D., Benus G.F., Voors A.A., van Gilst W.H., Samani N.J., Jaarsma T., van Veldhuisen D.J. Anaemia is associated with shorter leucocyte telomere length in patients with chronic heart failure. Eur. J. Heart Fail. 2010, 12:348-353.
66. Wong L.S., van der Harst P., de Boer R.A., Codd V., Huzen J., Samani N.J., Hillege H.L., Voors A.A., van Gilst W.H., Jaarsma T., van Veldhuisen D.J. Renal dysfunction is associated with shorter telomere length in heart failure. Clin. Res. Cardiol. 2009, 98:629-634.
67. Yang D.G., Liu L., Zheng X.Y. Cyclin-dependent kinase inhibitor p16(INK4a) and telomerase may co-modulate endothelial progenitor cells senescence. Ageing Res. Rev. 2008, 7:137-146.
68. Zheng H., Shen C.J., Qiu F.Y., Zhao Y.B., Fu G.S. Stromal cell-derived factor 1alpha reduces senescence of endothelial progenitor subpopulation in lectin-binding and DiLDL-uptaking cell through telomerase activation and telomere elongation. J. Cell Physiol. 2010, 223:757-763.